Epidemiology of Multiple Myeloma

Chapter
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 183)

Abstract

Multiple myelomas are a less frequent cancer site among both sexes. On a worldwide scale, it is estimated that about 86 000 incident cases occur annually, accounting for about 0.8% of all new cancer cases. About 63 000 subjects are reported to die from the disease each year, accounting for 0.9% of all cancer deaths. Geographically, the frequency is very unevenly distributed in the world with the highest incidence in the industrialised regions of Australia / New Zealand, Europe and North America. Incidence and mortality seem to be stable in Asian countries and to increase slowly over the decades among whites in the western countries. The etiology is poorly understood. This depends partly upon the fact that the risk factors which play a major role for malignant diseases in general, such as tobacco consumption and diet have not been found strongly involved into multiple myeloma etiology. Nevertheless, some consistency seems to be in the findings about a risk elevation with obesity and a slightly decreased risk with high fruit consumption. Despite some contradicting results, indications to a role of ionising radiation persist. Finally, infections with HIV and hepatitis C virus appear related to an elevated multiple myeloma risk. Currently, large efforts are undertaken to unravel the etiology of malignant lymphoma including those of multiple myeloma.

References

  1. Alexander D, Mink PJ, Adam HO, Cole P, Mandel JS, Oken MM, Trichopoulos D (2007) Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 120:40–61PubMedCrossRefGoogle Scholar
  2. Becker N, Deeg E, Nieters A (2004) Population-based study of lymphomas in Germany: rationale, study design and first results. Leuk Res 28:713–724PubMedCrossRefGoogle Scholar
  3. Becker N, de Sanjosé S, Nieters A, Maynadié M, Foretova L, Cocco PL, Staines A, Alvaro T, Vornanen M, Brennan P, Boffetta P (2007) Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph. Leuk Res 31:1365–1372PubMedCrossRefGoogle Scholar
  4. Becker N, Liebermann D, Wesch H, van Kaick G (2008) Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study. Eur J Cancer 44(9):1259–1268PubMedCrossRefGoogle Scholar
  5. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421–430PubMedCrossRefGoogle Scholar
  6. Bianchini F, Kaaks R, Vainio H (2002) Weight control and physical activity in cancer prevention. Obes Rev 3:5–8PubMedCrossRefGoogle Scholar
  7. Birmann BM, Giovannucci E, Rosner B, Anderson KC, Colditz GA (2007) Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev 16:1474–1478PubMedCrossRefGoogle Scholar
  8. Blair CK, Cerhan JR, Folsom AR, Ross JA (2005) Anthropometric characteristics and risk of multiple myeloma. Epidemiology 16:691–694PubMedCrossRefGoogle Scholar
  9. Boffetta P, Amstrong B, Linet M, Kasten C, Cozen W, Hartge P (2007) Consortia in cancer epidemiology: lessons from InterLymph. Cancer Epidemiol Biomarkers Prev 16(2):197–199PubMedCrossRefGoogle Scholar
  10. Britton JA, Khan AE, Rohrmann S, Becker N, Linseisen J, Nieters A, Kaaks R, TjØnneland A, Haljær J, Tang Serverinsen M, Overvad K, Rischon T, Boeing H, Trichopoulou A, Kalapothaki V, Trichopoulos D, Mattiello A, Tagliabue G, Sacerdote C, Peeters PHM, Bueno-de-Mesquita B, Ardanaz E, Navarro C, Jakszyn P, Altzibar JM, Hallmans G, Malmer B, Berglund G, Manjer J, Allen N, Key T, Bingham S, Besson H, Ferrari P, Jenab M, Boffetta P, Vineis P, Riboli E (2008) Anthropometric characteristics and non-Hodgkin’s lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica 93(11):1666–1677PubMedCrossRefGoogle Scholar
  11. Brown LM, Gridley G, Pottern LM, Baris D, Swanso CA, Silvermann DT, Hayes RB, Greenberg RS, Swanson GM, Schoenberg JB, Schwartz AG, Fraumeni JF, Jr. (2001) Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control 12:117–125PubMedGoogle Scholar
  12. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn Y-O, Amoros E, Ashmore P, Auvinen A, Bae J-M, Bernar J, Biau A, Cambalot E, Deboodt P, Diez Sacristan A, Eklöf M, Engels H, Engholm G, Gulis G, Habib RR, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K (2007) Radiation Res 167:396–416PubMedGoogle Scholar
  13. Coleman EA, Senner JW, Edwards BK (2008) Does multiple myeloma incidence vary by geographic area? J Ark Med Soc 105(4):89–91PubMedGoogle Scholar
  14. Costantini AS, Benvenuti A, Vineis P, Kriebel D, Tumino R, Ramazzotti V, Rodella S, Stagnaro E, Crosignani P, Amadori D, Mirabelli D, Sommani L, Belletti I, Troschel L, Romea L, Miceli G, Tozzi GA, Mendico I, Maltoni SA, Miligi L (2008) Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: Evidence from the Italian multicenter case-control study. Am J of Industrial Med 51:803–811PubMedGoogle Scholar
  15. Devesa SS, Fears T (1992) Non-Hodgkin´s Lymphoma time trends: United States and international data. Cancer Res (Suppl) 52:5432s–5440sPubMedGoogle Scholar
  16. Doll R, Peto R (1981) The causes of cancer. J Natl Cancer Inst 66:1191–1308PubMedGoogle Scholar
  17. Duberg AS, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, Black E, Ekdahl K (2005) Non-Hodgkin´s lymphoma and other nonhepatic malignanies in Swedish patients with hepatitis C virus infection. Hepatology 41:652–659PubMedGoogle Scholar
  18. Ge NL, Rudikoff S (2000) Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood 96:2856–2861PubMedGoogle Scholar
  19. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ (1998) Spectrum of AIDS-assoicated malignant disorders. Lancet 351:1833–1839PubMedGoogle Scholar
  20. Grulich AE, Wan X, Law MG, Coates M, Kaldo JM (1999) Risk of cancer in people with AIDS. AIDS 13:839–843PubMedGoogle Scholar
  21. Harvard Report on Cancer Prevention (1996) Volume 1: Causes of human cancer. Cancer Causes Control 7(Suppl 1):S55–S58Google Scholar
  22. Hemminki K, Li X, Czene K (2004) Familial risk of cance: data for clinical counseling and cancer genetics. Int J Cancer 108:109–114PubMedCrossRefGoogle Scholar
  23. IARC (2002) IARC Handbooks of cancer prevention. Volume 6. Weight control and physical activity. IARC Press, LyonGoogle Scholar
  24. Kaaks R, Lukanova A (2002) Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. Ann NY Acad Sci 963:268–281PubMedCrossRefGoogle Scholar
  25. Larsson SC, Wolk A (2007) Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer 121:2512–2516PubMedCrossRefGoogle Scholar
  26. Nieters A, Deeg E, Becker N (2006a) Tobacco and alcohol consumption and risk of lymphoma: results of a population-based case-control study in Germany. Int J Cancer 118:422–430PubMedCrossRefGoogle Scholar
  27. Nieters A, Kallinowski B, Brennan P, Ott M, Maynadié M, Benavente Y, Foretova L, Cocco PL, Staines A, Vornanen M, Whitby D, Boffetta P, Becker N, de Sanjosé S (2006b) Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 131:1879–1886PubMedCrossRefGoogle Scholar
  28. Nieters A, Rohrmann S, Becker N, Linseisen J, Ruediger T, Overvad K, TjØnneland A, Ohlsen A, Allen NE, Travis RC, Bingham S, Khaw KT, Ardanaz E, Redondo ML, Basterrechea M, Martinez C, Tormo MJ, Rosso S, Tagliabue G, Masala G, Mattiello A, Tumino R, Boeing H, Bergmann M, Kaaks R, Trichopoulou A, Trichopoulos D, Peeters PH, Bueno-de-Mesquita B, Boffetta P, Brennan P, Ferrari P, Neasham D, Lund E, Berglund G, Manjer J, Hallmans G, Johansson I, Vineis P, Riboli E (2008) Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition. Am J Epidemiol 167:1081–1089PubMedCrossRefGoogle Scholar
  29. Oh SW, Yoon YS, Shin SA (2005) Effects of excess weight on cancer incidences dependng on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23:4742–4754PubMedCrossRefGoogle Scholar
  30. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 195:259–268PubMedCrossRefGoogle Scholar
  31. Parkin M, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRefGoogle Scholar
  32. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsui T, Nonaka H, Thompson DE, Soda M, Mabuchi K (1994) Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res 137:S68–S97PubMedCrossRefGoogle Scholar
  33. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaboration (2007) Cancer incidence and mortality in relation to body mass index in the Million Women study: cohort study. BMJ 335(7630):1134, Epub 6 Nov 2007PubMedCrossRefGoogle Scholar
  34. Rohrmann S, Becker N, Linseisen J, Nieters A, Rüdiger T, Raaschou-Nielsen O, Tjonneland A, Johnsen HE, Overvad K, Kaaks R, Bergmann MM, Boeing H, Benetou V, Psaltopoulou T, Trichopoulou A, Masala G, Mattiello A, Krogh V, Tumino R, van Gils CH, Peeters PHM, Bas Bueno-de-Mesquita H, Ros MM, Lund E, Ardanaz E, Chirlaque M-D, Jakszyn P, Larranaga N, Losada A, Martinez-Garcia C, Agren A, Hallmans G, Berglund G, Manjer J, Allen NE, Key TJ, Bingham S, Khaw KT, Slimani N, Ferrari P, Boffetta P, Norat T, Vineis P, Riboli E (2007) Fruit and vegetable consumption and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 18:537–549PubMedCrossRefGoogle Scholar
  35. Tavani A, Pregnolato A, Negri E, Franceschi S, Serraino D, Carbone A, La Vecchia C (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260PubMedCrossRefGoogle Scholar
  36. Valjinac HD, Pekmezovic TH, Adanja BJ, Marinkovic JM, Kanazir MS, Suvajdizic ND, Colovic MD (2003) Case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma 50:79–83PubMedCrossRefGoogle Scholar
  37. Visfeldt J, Andersson M (1995) Pathoanatomical aspects of malignant haematological disorders among Danish patients exposed to thorium dioxide. APMIS 103:29–36PubMedCrossRefGoogle Scholar
  38. Wynder EL, Gori GB (1977) Contribution of the environment to cancer incidence: an epidemiologic exercise. JNCI 58:825–832PubMedGoogle Scholar
  39. Xu F, Gardner A, Tu Y, Michl P, Prager D, Lichtenstein A (1997) Multiple myeloma cells are protected against dexamethasone-included apoptosis by insulin-like growth factors. Br J Haematol 97:429–440PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.Division of Cancer EpidemiologyGerman Cancer Research CenterHeidelbergGermany

Personalised recommendations